Published in Immunology on April 01, 1995
Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res (1997) 1.56
Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res (2001) 1.17
Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor. Malar J (2004) 1.01
Genetic transformation of a Corynebacterial symbiont from the Chagas disease vector Triatoma infestans. Exp Parasitol (2008) 1.00
Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1996) 0.99
Functional expression of a single-chain anti-progesterone antibody fragment in the cytoplasm of a mutant Escherichia coli. Nucleic Acids Res (1995) 0.89
Effects of mutation at the D-JH junction on affinity, specificity, and idiotypy of anti-progesterone antibody DB3. Protein Sci (2006) 0.85
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem (1987) 34.69
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 6.14
Single-chain antigen-binding proteins. Science (1988) 5.29
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature (1989) 5.23
Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 3.38
"Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A (1993) 2.91
Escherichia coli secretion of an active chimeric antibody fragment. Science (1988) 2.29
In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A (1992) 2.08
A simple single-step procedure for small-scale preparation of Escherichia coli plasmids. Nucleic Acids Res (1990) 1.89
In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst (1990) 1.61
A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry (1990) 1.60
Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry (1992) 1.46
High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology (N Y) (1992) 1.43
Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature (1993) 1.39
Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature (1993) 1.38
Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Biotechnology (N Y) (1992) 1.15
Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding. Immunol Rev (1992) 1.12
Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J Mol Biol (1993) 1.10
Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J Mol Biol (1994) 1.10
Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen. J Biol Chem (1991) 1.07
Monoclonal BALB/c anti-progesterone antibodies use family IX variable region heavy chain genes. Eur J Immunol (1987) 1.01
Progesterone monoclonal antibody blocks pregnancy in mice. Nature (1982) 1.01
Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol Immunol (1994) 1.00
Optimizing protein folding to the native state in bacteria. Curr Opin Biotechnol (1991) 1.00
A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry (1990) 0.99
Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Biotechnology (N Y) (1993) 0.95
The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in Escherichia coli. Biotechnology (N Y) (1993) 0.95
Efficacy and specificity of monoclonal antibodies to progesterone in preventing the establishment of pregnancy in the mouse. J Endocrinol (1988) 0.94
Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines. Protein Eng (1991) 0.93
Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes. Immunology (1987) 0.92
Anti-idiotypic sera against monoclonal anti-progesterone antibodies: production in rabbits and rats and characterization of specificity. Immunology (1986) 0.90
Characterization of germ-line genes of the VGAM3.8 VH gene family from BALB/c mice. J Immunol (1992) 0.83
Production and secretion of a bifunctional staphylococcal protein A::antiphytochrome single-chain Fv fusion protein in Escherichia coli. Gene (1992) 0.81
Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: recovery of active FV fragments. Mol Immunol (1992) 0.78
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A (1991) 5.94
Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science (1989) 5.73
Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. J Exp Med (1975) 4.64
Antigen-specific T-cell factor in cell cooperation: physical properties and mapping in the left-hand (K) half of H-2. J Exp Med (1974) 4.10
Two genes in the major histocompatibility complex control immune response. Nature (1975) 4.08
T cell factor which can replace T cells in vivo. Nature (1974) 3.10
Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A (2000) 2.63
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Production of an H--2-related suppressor factor by a hybrid T-cell line. Nature (1979) 2.22
Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res (2000) 2.13
In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A (1992) 2.08
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
The challenges of conducting clinical research: one research team's experiences. Clin Nurse Spec (2001) 2.05
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol (2000) 2.03
Neurotransmitter transporters in the central nervous system. Pharmacol Rev (1999) 1.98
Antigen-specific T-cell factors in the genetic control of the immune response to poly(Tyr,Glu)-polyDLAla--polyLys. Evidence for T- and B-cell defects in SJL mice. J Exp Med (1975) 1.98
Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A (2001) 1.88
A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science (2000) 1.84
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res (1997) 1.56
The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog (2005) 1.56
Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. J Biol Chem (2000) 1.55
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol (1997) 1.53
Structure of an antigen-specific suppressor factor produced by a hybrid T-cell line. Nature (1979) 1.43
Antibodies without immunization. Science (1992) 1.41
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J (1996) 1.41
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J (1996) 1.40
CGRP receptor blockade by MK-8825 alleviates allodynia in infraorbital nerve-ligated rats. Eur J Pain (2014) 1.39
Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett (1997) 1.39
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol (1996) 1.39
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet (1989) 1.38
[Determination of mannitol and lactulose in urine by capillary gas chromatography]. Ann Biol Clin (Paris) (1992) 1.38
Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature (1993) 1.38
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol (1985) 1.37
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry (2011) 1.37
The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J Immunol (2000) 1.36
Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci (2001) 1.36
Antigenic competition. Curr Top Microbiol Immunol (1973) 1.34
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci (1986) 1.31
Carotid-cavernous fistulas: diagnosis with spiral CT angiography. AJNR Am J Neuroradiol (2000) 1.29
Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci (2000) 1.29
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int (1995) 1.22
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol Psychiatry (2007) 1.19
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience (1999) 1.18
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol (1995) 1.18
Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res (2001) 1.17
Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) (1999) 1.16
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry (2002) 1.15
Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology (2000) 1.15
Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. J Pharmacol Exp Ther (1990) 1.15
Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem (1998) 1.14
Evidence for complex nuclear inheritance in a pedigree with nonsyndromic deafness due to a homoplasmic mitochondrial mutation. Am J Med Genet (1998) 1.14
Demonstration of suppressor T cells in a population of 'educated' T cells. Nature (1974) 1.13
Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol (2000) 1.13
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol (1978) 1.11
Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J Mol Biol (1993) 1.10
Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii. Med Vet Entomol (1999) 1.10
Acupuncture-like stimulation induces a heterosegmental release of Met-enkephalin-like material in the rat spinal cord. Pain (1991) 1.10
Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J Mol Biol (1994) 1.10
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res (1997) 1.09
Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry (2000) 1.08
Studies on antigenic competition. II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition. Immunology (1972) 1.08
Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure (2001) 1.07
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol (1997) 1.07
Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? AJNR Am J Neuroradiol (2006) 1.06
Hearing loss due to the mitochondrial A1555G mutation in Italian families. Am J Med Genet (1998) 1.06
Induction of an antibody response in cultures of human peripheral blood lymphocytes. J Exp Med (1976) 1.04
Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system. Eur J Neurosci (2002) 1.04
Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse (1992) 1.03
[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem (1985) 1.03
Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl) (2001) 1.03
Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc Natl Acad Sci U S A (1998) 1.02
Stage-dependent localization of a novel gene product of the malaria parasite, Plasmodium falciparum. J Biol Chem (2001) 1.02
Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci (1999) 1.02
Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J (1999) 1.01
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol (2000) 1.01
Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J Biol Chem (2000) 1.01
Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Lab Invest (1999) 1.01
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci (2001) 1.01
Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse (1996) 1.00
Antigen-specific T-cell factor in cell cooperation and genetic control of the immune response. Fed Proc (1976) 0.99
Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci U S A (1999) 0.98
Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci (2002) 0.98
Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord. J Pharmacol Exp Ther (1986) 0.98
Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display. J Immunol Methods (1999) 0.98
Modulation of antibody display on M13 filamentous phage. J Immunol Methods (1998) 0.98
Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J Neurosci Res (1996) 0.98
On the use of combinatorial antibody libraries to clone the "fossil record" of an individual's immune response. Proc Natl Acad Sci U S A (1991) 0.98
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Res (1993) 0.98
Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther (1995) 0.97